Skip to main content
Journal ArticleOPEN ACCESS

Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase– and ROS1 Fusion–Positive Non–Small Cell Lung Cancer in India

  • Gupta D
  • Gupta N
  • Singh N
  • et al.
JCO Global Oncology (2024) (10)
DOI: 10.1200/go.23.00260
2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Crizotinib & Ceritinib prices should be reduced significantly for inclusion in Indiaâ€s PMJAY scheme.

Cite

CITATION STYLE

APA

Gupta, D., Gupta, N., Singh, N., & Prinja, S. (2024). Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase– and ROS1 Fusion–Positive Non–Small Cell Lung Cancer in India. JCO Global Oncology, (10). https://doi.org/10.1200/go.23.00260

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free